The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The MicroRNA Spectrum in 12 Body Fluids
Abstract
BACKGROUND: MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in regulating various biological processes through their interaction with cellular messenger RNAs. Extracellular miRNAs in serum, plasma, saliva, and urine have recently been shown to be associated with various pathological conditions including cancer. METHODS: With the goal of assessing the distribution of miRNAs and demonstrating the potential use of miRNAs as biomarkers, we examined the presence of miRNAs in 12 human body fluids and urine samples from women in different stages of pregnancy or patients with different urothelial cancers. Using quantitative PCR, we conducted a global survey of the miRNA distribution in these fluids. RESULTS: miRNAs were present in all fluids tested and showed distinct compositions in different fluid types. Several of the highly abundant miRNAs in these fluids were common among multiple fluid types, and some of the miRNAs were enriched in specific fluids. We also observed distinct miRNA patterns in the urine samples obtained from individuals with different physiopathological conditions. CONCLUSIONS: MicroRNAs are ubiquitous in all the body fluid types tested. Fluid type–specific miRNAs may have functional roles associated with the surrounding tissues. In addition, the changes in miRNA spectra observed in the urine samples from patients with different urothelial conditions demonstrates the potential for using concentrations of specific miRNAs in body fluids as biomarkers for detecting and monitoring various physiopathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nevertheless, hsa-mir-548 family members have been detected from other body fluids in addition to FF: hsa-miR-548b-5p, hsa-miR-548c-5p and hsa-miR-548i [57], and hsa-miR-548a-3p [58] in blood serum samples, hsa-miR-548b-3p in blood plasma, bronchial lavage and peritoneal fluid, and hsa-miR-548d-5p in amniotic fluid [59].”
From Hsa-mir-548 family expression in human reproductive tissues (2021) · cites this paper as [59]
In the citing paper
“they are detectable in various biological fluids (Weber et al., 2010).”
From Acute Cerebral Ischemia Increases a Set of Brain-Specific miRNAs in Serum Small Extracellular Vesicles (2022) · cites this paper as Weber et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
Self-citationAlterations of the microRNA network cause neurodegenerative disease
Hébert, S. S., & De Strooper, B. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.12.003 · Cited by 452
Kuokkanen, S., Chen, B., Ojalvo, L., Benard, L., Santoro, N., & Pollard, J. W. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.109.081059 · Cited by 288
Flagged first, then by citations
Research works printed but not linked: 27
- Nelson, 2003, The microRNA world: small is mighty, Trends Biochem Sci, 28, 534, 10.1016/j.tibs.2003.08.005 · DOI
- Mishima, 2007, RT-PCR-based analysis of microRNA (miR-1 and -124) expression in mouse CNS, Brain Res, 1131, 37, 10.1016/j.brainres.2006.11.035 · DOI · Paper page
- Chang, 2004, miR-122, a mammalian liver-specific microRNA, is processed from HCR mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1, RNA Biol, 1, 106, 10.4161/rna.1.2.1066 · DOI
- Chen, 2009, MicroRNA signatures in liver diseases, World J Gastroenterol, 15, 1665, 10.3748/wjg.15.1665 · DOI
- Nimmo, 2009, An elegant miRror: microRNAs in stem cells, developmental timing and cancer, Chromosoma, 118, 405, 10.1007/s00412-009-0210-z · DOI
- Shi, 2009, MicroRNA in cell differentiation and development, Sci China C Life Sci, 52, 205, 10.1007/s11427-009-0040-5 · DOI
- Mocellin, 2009, Oncomirs: from tumor biology to molecularly targeted anticancer strategies, Minirev Med Chem, 9, 70, 10.2174/138955709787001802 · DOI
- Xiao, 2009, MicroRNA control in the immune system: basic principles, Cell, 136, 26, 10.1016/j.cell.2008.12.027 · DOI
- Sun, 2008, Small RNAs in development and disease, J Am Acad Dermatol, 59, 725, 10.1016/j.jaad.2008.08.017 · DOI
- Cortez, 2009, MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases, Exp Opin Biol Ther, 9, 703, 10.1517/14712590902932889 · DOI
- Hanke, A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer, Urol Oncol
- Zubakov, 2010, MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation, Int J Leg Med, 124, 217, 10.1007/s00414-009-0402-3 · DOI
- Park, 2009, Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection, Clin Cancer Res, 15, 5473, 10.1158/1078-0432.CCR-09-0736 · DOI
- Huang, 2010, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, Int J Cancer, 127, 118, 10.1002/ijc.25007 · DOI
- Rosell, 2009, Circulating MicroRNA signatures of tumor-derived exosomes for early diagnosis of non-small-cell lung cancer, Clin Lung Cancer, 10, 8, 10.3816/CLC.2009.n.001 · DOI
- Gilad, 2008, Serum microRNAs are promising novel biomarkers, PLoS ONE, 3, e3148, 10.1371/journal.pone.0003148 · DOI
- Alvarez, 2007, Bladder cancer biomarkers: current developments and future implementation, Curr Opinion Urol, 17, 341, 10.1097/MOU.0b013e3282c8c72b · DOI
- Kikuchi, 2004, Tumor markers of urinary tract carcinoma [in Japanese], Rinsho Byori, 52, 371
- Simpson, 2009, Exosomes: proteomic insights and diagnostic potential, Exp Rev Proteom, 6, 267, 10.1586/epr.09.17 · DOI
- Rabinowits, 2009, Exosomal microRNA: a diagnostic marker for lung cancer, Clin Lung Cancer, 10, 42, 10.3816/CLC.2009.n.006 · DOI
- Lotvall, 2007, Cell to cell signalling via exosomes through esRNA, Cell Adh Migr, 1, 156, 10.4161/cam.1.3.5114 · DOI
- Card, 2008, Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells, Mol Cell Biol, 28, 6426, 10.1128/MCB.00359-08 · DOI
- Zovoilis, 2008, Multipotent adult germline stem cells and embryonic stem cells have similar microRNA profiles, Mol Hum Reprod, 14, 521, 10.1093/molehr/gan044 · DOI
- Liang, 2007, Characterization of microRNA expression profiles in normal human tissues, BMC Genom, 8, 166, 10.1186/1471-2164-8-166 · DOI · Paper page
- Smith, 2009, Management of upper tract urothelial carcinoma, Adv Urol, 492462
- Nguyen, 2008, Defining the role of NMP22 in bladder cancer surveillance, World J Urol, 26, 51, 10.1007/s00345-007-0226-z · DOI
- Wang, Export of microRNAs and microRNA-protective protein by mammalian cells, Nucl Acids Res
Cited by
Sorted by citations
Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00402 · Cited by 5,287
Lu, T. X., & Rothenberg, M. E. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.034 · Cited by 2,425
The host shapes the gut microbiota via fecal microRNA
Liu, S., da Cunha, A. P., Rezende, R. M., Cialic, R., Wei, Z., Bry, L., Comstock, L. E., Gandhi, R., & Weiner, H. L. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2015.12.005 · Cited by 808
MicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
Breast milk, a source of beneficial microbes and associated benefits for infant health
Lyons, K. E., Ryan, C. A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2020) · Nutrients · doi:10.3390/nu12041039 · Cited by 613
Metadata
- Authors
- Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K.
- Affiliations
- Institute for Systems Biology, 1441 North 34th St., Seattle, WA 98103
- Department of Urology
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-11-01
- Volume
- 56
- Issue
- 11
- Pages
- 1733-1741
- ISSN
- 0009-9147
- 1530-8561
- PMC
- PMC4846276
- Cited by
- 2,477
- References
- 4
- Language
- en
- Funders
- Department of Defense (W911SR-07-C-0101, HDTRA 1-08-C-0023)
- NIH
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
